Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:33 am Sale | 2024-09-30 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 3,791,420 7.080% | -1,364,879 (-26.47%) | Filing History |
| 2024-11-12 09:33 am Purchase | 2024-09-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Adage Capital Management, L.P. | 3,322,146 8.550% | 3,322,146 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | AURA BIOSCIENCES INC AURA | Adage Capital Management, L.P. | 4,881,125 9.840% | 4,881,125 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Adage Capital Management, L.P. | 369,097 9.990% | 369,097 (New Position) | Filing History |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | HERON THERAPEUTICS INC HRTX | Adage Capital Management, L.P. | 8,850,000 5.840% | 8,850,000 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | IMMUNIC INC IMUX | Adage Capital Management, L.P. | 559,441 6.210% | 559,441 (New Position) | Filing History |
| 2024-11-12 09:31 am Unchanged | 2024-09-30 | 13G | MOLECULAR TEMPLATES INC NE MTEM | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Adage Capital Management, L.P. | 218,813 7.120% | 218,813 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Adage Capital Management, L.P. | 1,419,792 3.290% | 1,419,792 (New Position) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Adage Capital Management, L.P. | 2,597,736 7.860% | 2,597,736 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | UROGEN PHARMA LTD URGN | Adage Capital Management, L.P. | 3,735,741 8.870% | 3,735,741 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | SOLID BIOSCIENCES INC SLDB | Adage Capital Management, L.P. | 1,754,159 4.550% | 1,754,159 (New Position) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | ENGENE HLDGS INC ENGN | Adage Capital Management, L.P. | 2,329,768 5.270% | 2,329,768 (New Position) | Filing History |
| 2024-11-04 4:26 pm Purchase | 2024-10-29 | 13D | GLYCOMIMETICS INC GLYC | Adage Capital Management, L.P. | 50,912 7.900% | 50,912 (New Position) | Filing History |
| 2024-10-22 4:15 pm Purchase | 2024-10-22 | 13D | ORUKA THERAPEUTICS INC ORKA | Adage Capital Management, L.P. | 175,000 0.500% | 75,000 (+75.00%) | Filing History |
| 2024-06-03 4:30 pm Purchase | 2024-05-31 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Adage Capital Management, L.P. | 4,210,429 9.990% | 4,210,429 (New Position) | Filing History |
| 2024-05-01 5:08 pm Unchanged | 2024-04-30 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 5,156,299 9.900% | 0 (Unchanged) | Filing History |
| 2024-04-30 8:53 pm Purchase | 2024-04-30 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 5,156,299 10.350% | 5,156,299 (New Position) | Filing History |
| 2024-04-05 4:05 pm Purchase | 2024-04-03 | 13D | ARCA BIOPHARMA INC PAR $.0 ABIO | Adage Capital Management, L.P. | 100,000 8.280% | 100,000 (New Position) | Filing History |